Feigin, VL, et al.
Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurology
2009; 8: 355–369.
Ovbiagele, B, Nath, A. Increasing incidence of ischaemic stroke in patients with HIV infection. Neurology
2011; 76: 444–450.
Cole, JW, et al.
Acquired immunodeficiency syndrome and the risk of stroke. Stroke
2004; 35: 51–56.
World Health Organisation. Statistical Information System, 2014. Causes of death: mortality and health status (http://www.who.int/research/en/). Accessed 20 September 2014.
Atadzhanov, M, et al.
Stroke characteristics and outcomes of adult patients admitted to the University Teaching Hospital, Lusaka, Zambia. Open General and Internal Medicine Journal
2012; 5: 3–8.
Chow, FC, et al.
Comparison of ischaemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system. Journal of Acquired Immune Deficiency Syndrome
2012; 60: 351–358.
Palomeras, E, Roquer, J. Cerebrovascular disease as a form of presentation of HIV infection. Neurologia
1996; 11: 346–349.
Anunnatsiri, S, et al.
Disease patterns among Thai adult population: an analysis of data from the hospitalization national health insurance system. Journal of the Medical Association of Thailand
2012; 95: S74–80.
Heikinheimo, T, et al.
Stroke outcomes in Malawi, a country with high prevalence of HIV: a prospective follow-up study. PLoS ONE
2012; 7(3): e33765.
Tipping, B, et al.
Stroke in patients with human immunodeficiency virus infection. Journal of Neurology, Neurosurgery and Psychiatry
2007; 78: 1320–1324.
Mlay, M, Bakari, M. The prevalence of HIV among patients admitted with stroke at the Muhimbili National Hospital, Dar es Salam, Tanzania. Tanzania Journal of Health Research
2010; 12: 1–12.
Benjamin, LA, et al.
HIV infection and stroke: current perspectives and future directions. Lancet Neurology
2012; 11: 878–890.
Ortiz, G, et al.
Mechanisms of ischaemic stroke in HIV-infected patients. Neurology
2007; 68: 1257–1261.
Hoffmann, M, et al.
Cerebrovascular disease in young, HIV-infected, black Africans in the KwaZulu Natal province of South Africa. Journal of NeuroVirology
2000; 6: 229–236.
Kumar, S, Selim, M, Caplan, L. Medical complications after stroke. Lancet Neurology
2010; 9: 105–118.
Whiteley, W, et al.
Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Medicine
2009; 6(9): e1000145.
Fugate, JE, et al.
Infectious causes of stroke. Lancet Infectious Diseases
2014; 14: 869–880.
Gnonlonfoun, D, et al.
Human immunodeficiency virus infection, stroke severity and mortality predictive indicator in Centre National Hospitalier et Universitaire-Hubert Koutoukou Maga (CNHU-HKM) Cotonou, Benin. African Journal of Neurological Sciences
2013; 32: 14–19.
Weber, R, et al.
Decreasing mortality and changing patterns of causes of death in the Swiss HIV cohort. HIV Medicine
2013; 14: 195–207.
Mochan, A, Modi, M, Modi, G. Stroke in black South African HIV-positive patients: a prospective analysis. Stroke
2003; 34: 10–15.
Kwok, CS, et al.
Association between prestroke disability and inpatient mortality and length of acute hospital stay after acute stroke. Journal of the American Geriatrics Society
2012; 60: 726–732.
Chasombat, S, et al.
The National Access to Antiretroviral Program for PHA (NAPHA) in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health
2006, 37: 704–715.